The table below shows Bioventus Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$132.09M
$138.65M
$147.66M
$123.88M
$138.96M
$151.22M
Cost of revenue
$41.32M
$44.42M
$45.57M
$40.82M
$45.41M
$47.58M
Gross profit
$90.77M
$94.23M
$102.09M
$83.06M
$93.55M
$103.64M
R&D
$2.47M
$2.92M
$3.17M
$3.01M
$3.84M
$4.21M
BVS annual revenue (10-K history)
Bioventus Inc. reported annual revenue of $568.09M for fiscal year 2025. That is down 0.9% from $573.28M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $340.14M (FY 2019) to $568.09M. Figures come from the company's audited annual reports as filed with the SEC.